Abbott has announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the ...

Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...

In a report released on December 20, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

In a report released today, Adam Maeder from Piper Sandler maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

M&T Bank Corp lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% during the 3rd quarter, ...

Abbott is one of the biggest healthcare companies in the world. With over 400 consecutive quarterly dividend payouts and 53 ...

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and ...

Abbott (NYSE: ABT) today announced the successful completion of the world's first in-human leadless left bundle branch area ...

Abbott Laboratories' board has raised the quarterly dividend by 7.3%, to 59 cents, making it 53 straight years that the healthcare-products company has boosted its payout. The new quarterly rate, ...

Abbott is a global healthcare leader that helps people live ... with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.

Maybe artificial intelligence will keep up its momentum, or perhaps interest in weight loss-focused pharmaceutical companies will increase. Whatever the answer is, it probably won't be dividend ...

Dividend stocks will supercharge your portfolio in good times and limit declines during tough times. It’s important to choose ...